OMER compared with CORT: revenue, margins and what each company keeps, and the suppliers and customers both name

OMEROmeros Corp

Mkt capRevenueRevenue

CORTCorcept Therapeutics Inc

Mkt capRevenueRevenue

Compare

OMEROmeros Corp

CORTCorcept Therapeutics Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

OMER

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±12.3%▲+26.55%×2.16

May 14 '26±10.6%▼−7.65%×0.73

Q1 FY26±15.9%▲+14.39%×0.91

Jan 8 '26±15.0%▼−4.54%×0.30

CORT1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▲+27.29%—

= impliedOMER realized, solidCORT realized, hatchedOne scale, both sides: full bar = 28%× = |realized| ÷ impliedSource: market data

OMEROmeros Corp

17.81▼−3.39%· post 18.09

Mkt cap$1.3BRevenue$29MQ2 FY26Revenue—

CORTCorcept Therapeutics Inc

80.46▼−0.81%· post 82.03

ClosedNov 2 '26

Mkt cap$8.7BRevenue$256MQ2 FY26Revenue$761MFY25

Compare

ClosedNov 2 '26

OMEROmeros Corp

CORTCorcept Therapeutics Inc

17.81▼−3.39%post 18.09

Price

80.46▼−0.81%post 82.03

$1.3B

Mkt cap

$8.7B

Q2 FY26$29M

Revenue

$256MQ2 FY26

—

Revenue

$761MFY25

OMER17.81▼−3.39%vsCORT80.46▼−0.81%ClosedNov 2 '26